Status:
COMPLETED
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
i3 Innovus
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
Brief Summary
Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and pr...
Eligibility Criteria
Inclusion
- Clinical diagnosis of possible or probable Alzheimer's disease, with or without vascular elements
- The primary caregiver can be identified
- The patient and his/her primary caregiver are both willing and able to participate in the study
Exclusion
- Patient or caregiver affected by alcohol or narcotics to the extent that it interferes with the completion of the study
- Patient or caregiver does not understand English
- Patient and/ or caregiver is the physician or physician's staff
- Patient and/ or caregiver is a family member of the physician or physician's staff
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT00698165
Start Date
June 1 2007
End Date
January 1 2009
Last Update
February 20 2009
Active Locations (82)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Northport, Alabama, United States
2
Research Site
Phoenix, Arizona, United States
3
Research Site
Brentwood, California, United States
4
Research Site
Fresno, California, United States